Drug target · AVPR1B
V1B receptor
Arginine vasopressin receptor 1B
2 compounds in the CNS pipeline act on V1B receptor.
Compounds targeting V1B receptor
| Compound | Action | Affinity | Lead program | Developer |
|---|---|---|---|---|
| Nelivaptan (BH-200)primarySmall molecule | Antagonist | — | Phase 2Major depressive disorder | Sanofi |
| Brezivaptan (TS-121 / ANC-501)primarySmall molecule | Antagonist | — | DiscontinuedMajor depressive disorder | Taisho Pharmaceutical Co., Ltd. |